SK Life Science Labs
Nathan Kendsersky is a Scientist specializing in Computational Biology at SK Life Science Labs since September 2022. Previously, Nathan served as a PhD Candidate at the University of Pennsylvania School of Medicine from January 2017 to September 2022, where research focused on neuroblastoma subtypes and candidate immunotherapeutic targets, resulting in presentations at various conferences and contributions as co-author on multiple manuscripts. Nathan also held roles such as Pharm4GOOD Outreach Co-Chair, Graduate Teaching Assistant, and Mentor for the Alex's Lemonade Stand Foundation Summer Fellow program. Prior experience includes work as an Undergraduate Student Researcher at the University of Pittsburgh, with a focus on chemical agonists in neurodegenerative disease research. Nathan holds a PhD in Pharmacology from the University of Pennsylvania School of Medicine and a Bachelor of Science in Biochemistry and Molecular Biology from the University of Pittsburgh.
This person is not in any teams
SK Life Science Labs
SK Life Science Labs, a subsidiary of SK Biopharmaceuticals, is a U.S. biotech company focused on the discovery of transformative medicines through targeted protein degradation (TPD). We discover and develop therapies through precise degradation of disease-causing proteins. Our team takes a target-centric approach through AI enabled target identification. Our core TPD platform, built upon a strong TPD knowledge base, novel E3 ligands & linkers, and machine-learning based ternary complex modeling, is further complemented by a proprietary MOPED™ molecular glue platform. SK Life Science Labs integrates innovative platforms with deep drug-hunting expertise to defeat disease and improve patients’ lives. View our community guidelines here: http://bit.ly/3REsFKU